Imetelstat
Geron Corporation
['mds']
geron announces asco presentation reporting durable continuous transfusion independence with imetelstat in imerge phase 3 lower risk mds patients via 
Retired private equity investments - Smallcaps. My comments are all IMHO and not to be considered investment advice.